Molecular dissection of the RAS/RAF/MAPK pathway in primary and metastatic melanoma.

被引：0

作者：

Rother, J. ^{[1
]}

Bailey, J. ^{[1
]}

Alvarado, G. ^{[1
]}

Prieto, V. G. ^{[1
]}

Lazar, A. J. ^{[1
]}

Jones, D. ^{[1
]}

Hwu, W. J. ^{[1
]}

机构：

[1] MD Anderson Canc Ctr, Houston, TX USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8050

引用

页码：465S / 465S

页数：1

共 50 条

[31] Molecular alterations in the Ras-Raf-Erk (MAPK) pathway in metastatic hormone receptor positive (HR+)/HER2-breast cancer: Incidence and impact on clinical outcomes
Medford, Arielle
Niemierko, Andrzej
Moy, Beverly
Spring, Laura
Malvarosa, Giuliana
Younger, Jerry
Lanman, Richard B.
Nagy, Rebecca J.
Corcoran, Ryan Bruce
Isakoff, Steven J.
Ellisen, Leif W.
Juric, Dejan
Bardia, Aditya
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[32] Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition
Guardamagna, Mora
Berciano-Guerrero, Miguel-Angel
Villaescusa-Gonzalez, Beatriz
Perez-Ruiz, Elisabeth
Oliver, Javier
Lavado-Valenzuela, Rocio
Rueda-Dominguez, Antonio
Barragan, Isabel
Isabel Queipo-Ortuno, Maria
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
[33] THE PRINCIPLE OF EXCISION AND DISSECTION IN CONTINUITY FOR PRIMARY AND METASTATIC MELANOMA OF THE SKIN
PACK, GT
SCHARNAGEL, I
MORFIT, M
SURGERY, 1945, 17 (06) : 849 - 866
[34] Harmine suppresses hyper-activated Ras–MAPK pathway by selectively targeting oncogenic mutated Ras/Raf in Caenorhabditis elegans
Jiaojiao Ji
Jiang Yuan
Xiaoyu Guo
Ruifang Ji
Qinghua Quan
Mei Ding
Xia Li
Yonggang Liu
Cancer Cell International, 19
[35] Molecular changes in the EGFR pathway and RAS/RAF genes identify subtypes of metastatic and nonmetastatic colorectal cancer associated with different outcomes
Bahnassy, Abeer A.
Salem, Salem E.
Hussein, Nehal
Yousif, Hend F.
Al-Desouky, Marwa Iman
Zekri, Abdel-Rahman N.
CANCER RESEARCH, 2015, 75
[36] Acute heart failure due to reversible cardiomyopathy in patient under b-raf inhibitor for metastatic melanoma.
Mascarucci, M.
Bruni, F.
Maio, M.
Danielli, R.
Bova, G.
EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 446 - 446
[37] Ras/Raf-1/MAPK Pathway Mediates Response to Tamoxifen but not Chemotherapy in Breast Cancer Patients
McGlynn, Liane M.
Kirkegaard, Tove
Edwards, Joanne
Tovey, Sian
Cameron, David
Twelves, Chris
Bartlett, John M. S.
Cooke, Timothy G.
CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1487 - 1495
[38] Sprouty2 regulates positioning of retinal progenitors through suppressing the Ras/Raf/MAPK pathway
Jian Sun
Jaeho Yoon
Moonsup Lee
Yoo-Seok Hwang
Ira O. Daar
Scientific Reports, 10
[39] RAS/RAF/MAPK Pathway Mutations as Predictive Biomarkers in Middle Eastern Colorectal Cancer: A Systematic Review
Benmokhtar, Soukaina
Laraqui, Abdelilah
Hilali, Farida
Bajjou, Tahar
El Zaitouni, Sara
Jafari, Meryem
Baba, Walid
Elannaz, Hicham
Lahlou, Idriss Amine
Hafsa, Chahdi
Oukabli, Mohamed
Mahfoud, Tarik
Tanz, Rachid
Ichou, Mohamed
Ennibi, Khaled
Dakka, Nadia
Sekhsokh, Yassine
CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2024, 18
[40] Whole-genome characterization of lung adenocarcinomas lacking alterations in RTK/RAS/RAF/MAPK pathway
Carrot-Zhang, Jian
Devarakonda, Siddhartha
Robine, Nicolas
Yao, Xiaotong
Silva, Tiago C.
Damrauer, Jeff
Deshpande, Aditya
Tsao, Ming-Sound
Yao, Christina
Wong, Chris
Bao, Lisui
Choi, Hyo Young
Felau, Ina
Zenklusen, Jean C.
Robertson, Gordon
Trieua, Tuan
Liang, Wei-Wei
Zhou, Meng
Rheinbay, Esther
Hayes, Neil
Khurana, Ekta
Ding, Li
Laird, Peter
Elemento, Olivier
Weinstein, John
Kwiatkowski, David
Benz, Chris
Stuart, Josh
Yang, Lixing
Castro, Mauro
Travis, William
Hoadley, Katherine
Berman, Ben
Meyerson, Matthew
Govindan, Ramaswamy
Imielinski, Marcin
CANCER RESEARCH, 2020, 80 (16)

← 1 2 3 4 5 →